N-acetylcysteine for airway clearance during bronchiectasis flare-ups
Part of Lungs & breathing clinical trials.
This trial tests whether a medication called N-acetylcysteine (also known as NAC) helps clear mucus from the lungs faster in people with bronchiectasis who are hospitalized for a sudden worsening of symptoms. The goal is to see if it improves breathing and speeds up recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have been diagnosed with bronchiectasis (a condition where the airways in your lungs are damaged and widened, leading to mucus build-up).
- You are currently in the hospital because your breathing symptoms have suddenly gotten worse (called an acute exacerbation).
- You are not allergic to N-acetylcysteine (also known as NAC, a mucus-thinning medication).
- You do not currently smoke.
- If you are a woman, you are not pregnant or breastfeeding.
- You do not have a primary diagnosis of COPD (chronic obstructive pulmonary disease) or asthma.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if washing the lungs with acetylcysteine (a mucus-thinning medicine) during a bronchoscopy can help people with bronchiectasis who are having a flare-up. The goal is to see if it improves symptoms like cough and mucus.
This study tests whether placing a common antibiotic (amikacin) directly into the lungs during a bronchoscopy helps people with bronchiectasis recover faster from sudden flare-ups. Participation involves a bronchoscopy and a lung rinse, which may reduce infection and improve breathing.
This trial tests if breathing in a medication called acetylcysteine can help prevent lung infections in patients who are on a breathing machine. If you or a loved one is on a ventilator, this treatment might reduce the chance of getting ventilator-associated pneumonia.
This study tests if giving antibiotics (levofloxacin or gentamicin) directly into the lungs during a bronchoscopy can help patients with bronchiectasis who are in the hospital with a sudden worsening of symptoms or are on a breathing machine.
This trial tests whether inhaling a saltwater solution (hypertonic saline) twice a day for 12 weeks can help people with bronchiectasis who have a chronic cough and have had flare-ups in the past. It aims to see if this treatment reduces mucus and improves quality of life.
This study tests whether a common antibiotic called azithromycin can help prevent flare-ups (sudden worsening) of bronchiectasis—a lung condition where airways become permanently enlarged and damaged. Patients will take azithromycin or a placebo for 12 months to see if it reduces how often they get sick.
Hear when a new Broncheictasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.